
Keywords: Drug resistance; emerging communicable diseases; methicillin-resistant Staphylococcus aureus; molecular epidemiology; Panton-Valentine leukocidin; risk factors; sentinel surveillance; staphylococcal skin infections; travel medicine; trimethoprim-sulfame